Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 439

1.

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Levy A, Hendriks LEL, Le Péchoux C, Falk S, Besse B, Novello S, Dingemans AC, Hasan B, Reck M, Berghmans T, Faivre-Finn C; EORTC Lung Cancer Group (EORTC LCG).

Lung Cancer. 2019 Aug 13;136:145-147. doi: 10.1016/j.lungcan.2019.08.007. [Epub ahead of print]

PMID:
31520867
2.

The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.

Lee SM, Upadhyay S, Lewanski C, Falk S, Skailes G, Woll PJ, Hatton M, Lal R, Jones R, Toy E, Rudd R, Ngai Y, Edwards A, Hackshaw A.

Eur J Cancer. 2019 Sep 6;120:86-96. doi: 10.1016/j.ejca.2019.07.025. [Epub ahead of print]

3.

Genomic evidence of neo-sex chromosomes in the eastern yellow robin.

Gan HM, Falk S, Morales HE, Austin CM, Sunnucks P, Pavlova A.

Gigascience. 2019 Sep 1;8(9). pii: giz111. doi: 10.1093/gigascience/giz111.

4.

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.

Jones RP, Psarelli EE, Jackson R, Ghaneh P, Halloran CM, Palmer DH, Campbell F, Valle JW, Faluyi O, O'Reilly DA, Cunningham D, Wadsley J, Darby S, Meyer T, Gillmore R, Anthoney A, Lind P, Glimelius B, Falk S, Izbicki JR, Middleton GW, Cummins S, Ross PJ, Wasan H, McDonald A, Crosby T, Ting Y, Patel K, Sherriff D, Soomal R, Borg D, Sothi S, Hammel P, Lerch MM, Mayerle J, Tjaden C, Strobel O, Hackert T, Büchler MW, Neoptolemos JP; European Study Group for Pancreatic Cancer.

JAMA Surg. 2019 Sep 4. doi: 10.1001/jamasurg.2019.3337. [Epub ahead of print]

PMID:
31483448
5.

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.

Joharatnam-Hogan N, Cafferty F, Hubner R, Swinson D, Sothi S, Gupta K, Falk S, Patel K, Warner N, Kunene V, Rowley S, Khabra K, Underwood T, Jankowski J, Bridgewater J, Crossley A, Henson V, Berkman L, Gilbert D, Kynaston H, Ring A, Cameron D, Din F, Graham J, Iveson T, Adams R, Thomas A, Wilson R, Pramesh CS, Langley R; Add-Aspirin Trial Management Group.

Lancet Gastroenterol Hepatol. 2019 Aug 30. pii: S2468-1253(19)30289-4. doi: 10.1016/S2468-1253(19)30289-4. [Epub ahead of print]

PMID:
31477558
6.

Do Patients With Neurogenic Speech Sound Impairments Benefit From Auditory Priming With a Regular Metrical Pattern?

Aichert I, Lehner K, Falk S, Späth M, Ziegler W.

J Speech Lang Hear Res. 2019 Aug 29;62(8S):3104-3118. doi: 10.1044/2019_JSLHR-S-CSMC7-18-0172. Epub 2019 Aug 29.

PMID:
31465708
7.

Muscarinic receptors in energy homeostasis: Physiology and pharmacology.

Falk S, Lund C, Clemmensen C.

Basic Clin Pharmacol Toxicol. 2019 Aug 29. doi: 10.1111/bcpt.13311. [Epub ahead of print] Review.

PMID:
31464050
8.

The MTR4 helicase recruits nuclear adaptors of the human RNA exosome using distinct arch-interacting motifs.

Lingaraju M, Johnsen D, Schlundt A, Langer LM, Basquin J, Sattler M, Heick Jensen T, Falk S, Conti E.

Nat Commun. 2019 Jul 29;10(1):3393. doi: 10.1038/s41467-019-11339-x.

9.

Rhythm in speech and animal vocalizations: a cross-species perspective.

Ravignani A, Dalla Bella S, Falk S, Kello CT, Noriega F, Kotz SA.

Ann N Y Acad Sci. 2019 Jun 25. doi: 10.1111/nyas.14166. [Epub ahead of print] Review.

PMID:
31237365
10.

Evaluating the ability of citizen scientists to identify bumblebee (Bombus) species.

Falk S, Foster G, Comont R, Conroy J, Bostock H, Salisbury A, Kilbey D, Bennett J, Smith B.

PLoS One. 2019 Jun 24;14(6):e0218614. doi: 10.1371/journal.pone.0218614. eCollection 2019.

11.

Corrigendum to "Determination of adsorbable organically bound fluorine (AOF) and adsorbable organically bound halogens as sum parameters in aqueous environmental samples using combustion ion chromatography (CIC)" [Sci. Total Environ. 673 (2019) 384-391].

von Abercron E, Falk S, Stahl T, Georgii S, Hamscher G, Brunn H, Schmitz F.

Sci Total Environ. 2019 Oct 15;687:1. doi: 10.1016/j.scitotenv.2019.05.442. Epub 2019 Jun 12. No abstract available.

PMID:
31202007
12.

Levels, accumulation patterns and retrospective trends of perfluoroalkyl acids (PFAAs) in terrestrial ecosystems over the last three decades.

Falk S, Stahl T, Fliedner A, Rüdel H, Tarricone K, Brunn H, Koschorreck J.

Environ Pollut. 2019 Mar;246:921-931. doi: 10.1016/j.envpol.2018.12.095. Epub 2019 Jan 3.

PMID:
31159142
13.

Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Appel CK, Gallego-Pedersen S, Andersen L, Blancheflor Kristensen S, Ding M, Falk S, Sayilekshmy M, Gabel-Jensen C, Heegaard AM.

Sci Rep. 2019 May 9;9(1):7399. doi: 10.1038/s41598-019-43721-6.

14.

Determination of adsorbable organically bound fluorine (AOF) and adsorbable organically bound halogens as sum parameters in aqueous environmental samples using combustion ion chromatography (CIC).

von Abercron E, Falk S, Stahl T, Georgii S, Hamscher G, Brunn H, Schmitz F.

Sci Total Environ. 2019 Jul 10;673:384-391. doi: 10.1016/j.scitotenv.2019.04.068. Epub 2019 Apr 6. Erratum in: Sci Total Environ. 2019 Oct 15;687:1.

PMID:
30991328
15.

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group.

Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Erratum in: Lancet Oncol. 2019 Apr 2;:.

PMID:
30922733
16.

Failure to Debrief after Critical Events in Anesthesia Is Associated with Failures in Communication during the Event.

Arriaga AF, Sweeney RE, Clapp JT, Muralidharan M, Burson RC 2nd, Gordon EKB, Falk SA, Baranov DY, Fleisher LA.

Anesthesiology. 2019 Jun;130(6):1039-1048. doi: 10.1097/ALN.0000000000002649.

PMID:
30829661
17.

The centrosome protein AKNA regulates neurogenesis via microtubule organization.

Camargo Ortega G, Falk S, Johansson PA, Peyre E, Broix L, Sahu SK, Hirst W, Schlichthaerle T, De Juan Romero C, Draganova K, Vinopal S, Chinnappa K, Gavranovic A, Karakaya T, Steininger T, Merl-Pham J, Feederle R, Shao W, Shi SH, Hauck SM, Jungmann R, Bradke F, Borrell V, Geerlof A, Reber S, Tiwari VK, Huttner WB, Wilsch-Bräuninger M, Nguyen L, Götz M.

Nature. 2019 Mar;567(7746):113-117. doi: 10.1038/s41586-019-0962-4. Epub 2019 Feb 20.

PMID:
30787442
18.

Modulation of radiation sensitivity and antitumor immunity by viral pathogenic factors: Implications for radio-immunotherapy.

Rödel F, Martin D, Balermpas P, Wieland U, Winkelmann R, Riekmann T, Falk S, Rödel C, Fokas E.

Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):126-137. doi: 10.1016/j.bbcan.2018.12.006. Epub 2018 Dec 31. Review.

PMID:
30605716
19.

Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain.

Falk S, Appel CK, Bennedbæk HB, Al-Dihaissy T, Unger A, Dinkel K, Heegaard AM.

Eur J Pharmacol. 2019 Feb 15;845:48-55. doi: 10.1016/j.ejphar.2018.12.032. Epub 2018 Dec 22.

PMID:
30582910
20.

Biocytin Recovery and 3D Reconstructions of Filled Hippocampal CA2 Interneurons.

Economides G, Falk S, Mercer A.

J Vis Exp. 2018 Nov 20;(141). doi: 10.3791/58592.

PMID:
30531716
21.

Intraductal Papilloma Without Atypia on Image- Guided Breast Biopsy: Upgrade Rates to Carcinoma at Surgical Excision.

Leithner D, Kaltenbach B, Hödl P, Möbus V, Brandenbusch V, Falk S, Park C, Vogl TJ, Müller-Schimpfle M.

Breast Care (Basel). 2018 Oct;13(5):364-368. doi: 10.1159/000489096. Epub 2018 Jul 13.

22.

Acute cholecystitis - a cohort study in a real-world clinical setting (REWO study, NCT02796443).

Blythe J, Herrmann E, Faust D, Falk S, Edwards-Lehr T, Stockhausen F, Hanisch E, Buia A.

Pragmat Obs Res. 2018 Oct 25;9:69-75. doi: 10.2147/POR.S169255. eCollection 2018.

23.

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.

Robles-Zurita J, Boyd KA, Briggs AH, Iveson T, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Segelov E, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Hughes R, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan HS, Paul J.

Br J Cancer. 2018 Nov;119(11):1332-1338. doi: 10.1038/s41416-018-0319-z. Epub 2018 Nov 13.

24.

Concentrations and Distribution Patterns of Perfluoroalkyl Acids in Sewage Sludge and in Biowaste in Hesse, Germany.

Stahl T, Gassmann M, Falk S, Brunn H.

J Agric Food Chem. 2018 Oct 3;66(39):10147-10153. doi: 10.1021/acs.jafc.8b03063. Epub 2018 Sep 19.

PMID:
30192140
25.

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.

Gollins S, West N, Sebag-Montefiore D, Susnerwala S, Falk S, Brown N, Saunders M, Quirke P, Ray R, Parsons P, Griffiths G, Maughan T, Adams R, Hurt C.

Br J Cancer. 2018 Sep;119(6):697-706. doi: 10.1038/s41416-018-0209-4. Epub 2018 Aug 17.

26.

Distinct and evolutionary conserved structural features of the human nuclear exosome complex.

Gerlach P, Schuller JM, Bonneau F, Basquin J, Reichelt P, Falk S, Conti E.

Elife. 2018 Jul 26;7. pii: e38686. doi: 10.7554/eLife.38686.

27.

Corrigendum to "Sealing or infiltrating proximal carious lesions" [J. Dent. 74 (2018) 15-22].

Joachim K, Gerd G, Seif R, Falk S.

J Dent. 2018 Sep;76:137-138. doi: 10.1016/j.jdent.2018.06.015. Epub 2018 Jun 30. No abstract available.

PMID:
29970304
28.

Direct pericyte-to-neuron reprogramming via unfolding of a neural stem cell-like program.

Karow M, Camp JG, Falk S, Gerber T, Pataskar A, Gac-Santel M, Kageyama J, Brazovskaja A, Garding A, Fan W, Riedemann T, Casamassa A, Smiyakin A, Schichor C, Götz M, Tiwari VK, Treutlein B, Berninger B.

Nat Neurosci. 2018 Jul;21(7):932-940. doi: 10.1038/s41593-018-0168-3. Epub 2018 Jun 18.

29.

Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.

Diaz-delCastillo M, Christiansen SH, Appel CK, Falk S, Woldbye DPD, Heegaard AM.

Neuroscience. 2018 Aug 1;384:111-119. doi: 10.1016/j.neuroscience.2018.05.025. Epub 2018 May 29.

PMID:
29852245
30.

Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration?

Khoma O, Falk SE, Burton L, Van der Wall H, Falk GL.

Lung. 2018 Aug;196(4):491-496. doi: 10.1007/s00408-018-0128-4. Epub 2018 May 26.

PMID:
29804143
31.

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial.

Iveson TJ, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Haydon A, Glimelius B, Harkin A, Allan K, McQueen J, Scudder C, Boyd KA, Briggs A, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Harrison M, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan HS, Paul J.

Lancet Oncol. 2018 Apr;19(4):562-578. doi: 10.1016/S1470-2045(18)30093-7.

32.

Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain.

Falk S.

Pain. 2018 Jun;159(6):1127-1136. doi: 10.1097/j.pain.0000000000001197.

PMID:
29521811
33.

Structure of the nuclear exosome captured on a maturing preribosome.

Schuller JM, Falk S, Fromm L, Hurt E, Conti E.

Science. 2018 Apr 13;360(6385):219-222. doi: 10.1126/science.aar5428. Epub 2018 Mar 8.

PMID:
29519915
34.

Quality Improvement in Anesthesiology - Leveraging Data and Analytics to Optimize Outcomes.

Valentine EA, Falk SA.

Anesthesiol Clin. 2018 Mar;36(1):31-44. doi: 10.1016/j.anclin.2017.10.006. Review.

PMID:
29425597
35.

Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS, and NRAS (FOCUS4-D): a phase 2-3 randomised trial.

Adams R, Brown E, Brown L, Butler R, Falk S, Fisher D, Kaplan R, Quirke P, Richman S, Samuel L, Seligmann J, Seymour M, Shiu KK, Wasan H, Wilson R, Maughan T; FOCUS4 Trial Investigators.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):162-171. doi: 10.1016/S2468-1253(17)30394-1. Epub 2017 Dec 16.

36.

Reconstitution of the complete pathway of ITS2 processing at the pre-ribosome.

Fromm L, Falk S, Flemming D, Schuller JM, Thoms M, Conti E, Hurt E.

Nat Commun. 2017 Nov 27;8(1):1787. doi: 10.1038/s41467-017-01786-9.

37.

Glial control of neurogenesis.

Falk S, Götz M.

Curr Opin Neurobiol. 2017 Dec;47:188-195. doi: 10.1016/j.conb.2017.10.025. Epub 2017 Nov 13. Review.

38.

Natural and forced neurogenesis: similar and yet different?

Falk S, Karow M.

Cell Tissue Res. 2018 Jan;371(1):181-187. doi: 10.1007/s00441-017-2690-0. Epub 2017 Sep 25. Review. No abstract available.

PMID:
28948355
39.

The CONVERT Trial: Interpretation, Journey and Lessons Learnt.

Faivre-Finn C, Falk S, Blackhall F.

Clin Oncol (R Coll Radiol). 2017 Dec;29(12):811-813. doi: 10.1016/j.clon.2017.09.002. Epub 2017 Sep 19. No abstract available.

PMID:
28935186
40.

Frequent PD-L1 Expression in Malignant Melanomas of the Vulva.

Saleh B, Kriegsmann J, Falk S, Aulmann S.

Int J Gynecol Pathol. 2018 Sep;37(5):477-481. doi: 10.1097/PGP.0000000000000454.

PMID:
28914674
41.

Structural insights into the interaction of the nuclear exosome helicase Mtr4 with the preribosomal protein Nop53.

Falk S, Tants JN, Basquin J, Thoms M, Hurt E, Sattler M, Conti E.

RNA. 2017 Dec;23(12):1780-1787. doi: 10.1261/rna.062901.117. Epub 2017 Sep 7.

42.

Mpp6 Incorporation in the Nuclear Exosome Contributes to RNA Channeling through the Mtr4 Helicase.

Falk S, Bonneau F, Ebert J, Kögel A, Conti E.

Cell Rep. 2017 Sep 5;20(10):2279-2286. doi: 10.1016/j.celrep.2017.08.033.

43.

Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial.

Alderson D, Cunningham D, Nankivell M, Blazeby JM, Griffin SM, Crellin A, Grabsch HI, Langer R, Pritchard S, Okines A, Krysztopik R, Coxon F, Thompson J, Falk S, Robb C, Stenning S, Langley RE.

Lancet Oncol. 2017 Sep;18(9):1249-1260. doi: 10.1016/S1470-2045(17)30447-3. Epub 2017 Aug 4.

44.

Expanded Satellite Repeats Amplify a Discrete CENP-A Nucleosome Assembly Site on Chromosomes that Drive in Female Meiosis.

Iwata-Otsubo A, Dawicki-McKenna JM, Akera T, Falk SJ, Chmátal L, Yang K, Sullivan BA, Schultz RM, Lampson MA, Black BE.

Curr Biol. 2017 Aug 7;27(15):2365-2373.e8. doi: 10.1016/j.cub.2017.06.069. Epub 2017 Jul 27.

45.

The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Appel CK, Gallego-Pedersen S, Andersen L, Blancheflor Kristensen S, Ding M, Falk S, Sayilekshmy M, Gabel-Jensen C, Heegaard AM.

Sci Rep. 2017 Jul 6;7(1):4792. doi: 10.1038/s41598-017-05029-1. Erratum in: Sci Rep. 2019 May 9;9(1):7399.

46.

Grid-climbing Behaviour as a Pain Measure for Cancer-induced Bone Pain and Neuropathic Pain.

Falk S, Gallego-Pedersen S, Petersen NC.

In Vivo. 2017 Jul-Aug;31(4):619-623.

47.

Inhibition of DNA replication in Staphylococcus aureus by tegaserod.

Lacriola CJ, Falk SP, Weisblum B.

J Antibiot (Tokyo). 2017 Jul;70(8):918-920. doi: 10.1038/ja.2017.65. Epub 2017 May 31. No abstract available.

PMID:
28559577
48.

Speak on time! Effects of a musical rhythmic training on children with hearing loss.

Hidalgo C, Falk S, Schön D.

Hear Res. 2017 Aug;351:11-18. doi: 10.1016/j.heares.2017.05.006. Epub 2017 May 10.

PMID:
28552493
49.

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.

Petty RD, Dahle-Smith A, Stevenson DAJ, Osborne A, Massie D, Clark C, Murray GI, Dutton SJ, Roberts C, Chong IY, Mansoor W, Thompson J, Harrison M, Chatterjee A, Falk SJ, Elyan S, Garcia-Alonso A, Fyfe DW, Wadsley J, Chau I, Ferry DR, Miedzybrodzka Z.

J Clin Oncol. 2017 Jul 10;35(20):2279-2287. doi: 10.1200/JCO.2016.70.3934. Epub 2017 May 24.

PMID:
28537764
50.

The Future of Image-guided Radiotherapy.

Choudhury A, Budgell G, MacKay R, Falk S, Faivre-Finn C, Dubec M, van Herk M, McWilliam A.

Clin Oncol (R Coll Radiol). 2017 Oct;29(10):662-666. doi: 10.1016/j.clon.2017.04.036. Epub 2017 May 13. No abstract available.

PMID:
28511968

Supplemental Content

Support Center